Division of Nuclear Medicine PET Radiopharmaceutical Production Program, Ann Arbor, MI – FDA Inspections
Inspection records and compliance data for Division of Nuclear Medicine PET Radiopharmaceutical Production Program in Ann Arbor, Michigan. 3 FDA inspections on record (1 OAI), 2 Form 483s, last inspected September 17, 2025.
This profile covers Division of Nuclear Medicine PET Radiopharmaceutical Production Program based in Ann Arbor, Michigan, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 1
- VAI
- 2
- NAI
- 0
- Form 483s
- 2
- Warning letters
- 0
First inspected February 21, 2014. Last inspected September 17, 2025.
Most cited issue areas
- Written QA procedures established, followed2 inspections
- Adequate controls (general)1 inspection
- Contamination, chemical or physical change, deterioration1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 17, 2025 | OAI | Human Drugs · Drug Quality Assurance | 1282498 |
| March 7, 2019 | VAI | Human Drugs · Drug Quality Assurance | 1082112 |
| February 21, 2014 | VAI | Human Drugs · Drug Quality Assurance | 866735 |
Form 483s (1)
Companies with similar regulatory profiles, compliance history, and operations.
Name
Division of Nuclear Medicine PET Radiopharmaceutical Production Program
FEI Number
3010166888
Address
1301 Catherine St, 2276 Medical Science Bldg 1, Spc-5610, Ann Arbor, Michigan 48109, United States
Country
United States
ID: 262f6bbf-8bbc-4786-936b-f5dc1e452b48